Still betting on Nvidia? Our AI picked this stock instead; it’s up 96%+ THIS MONTH
Investing.com - Reneo Pharmaceuticals reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Reneo Pharmaceuticals announced earnings per share of $-0.530 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.578 on revenue of $0.00.
Reneo Pharmaceuticals 's are down 27% and is trading at $3.080 , still down 69.20% from its 52 week high of $10.00 set on Monday, December 27, 2021.
Reneo Pharmaceuticals shares gained 1.32% to trade at $3.080 in intra-day trade the report.
Reneo Pharmaceuticals follows other major Healthcare sector earnings this month
Reneo Pharmaceuticals's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar